258 related articles for article (PubMed ID: 24382837)
1. Antibody-mediated rejection as a contributor to previously unexplained early liver allograft loss.
O'Leary JG; Kaneku H; Demetris AJ; Marr JD; Shiller SM; Susskind BM; Tillery GW; Terasaki PI; Klintmalm GB
Liver Transpl; 2014 Feb; 20(2):218-27. PubMed ID: 24382837
[TBL] [Abstract][Full Text] [Related]
2. Application of complement component 4d immunohistochemistry to ABO-compatible and ABO-incompatible liver transplantation.
Salah A; Fujimoto M; Yoshizawa A; Yurugi K; Miyagawa-Hayashino A; Sumiyoshi S; Minamiguchi S; Uemoto S; Maekawa T; Haga H
Liver Transpl; 2014 Feb; 20(2):200-9. PubMed ID: 24470446
[TBL] [Abstract][Full Text] [Related]
3. Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation.
Musat AI; Pigott CM; Ellis TM; Agni RM; Leverson GE; Powell AJ; Richards KR; D'Alessandro AM; Lucey MR
Liver Transpl; 2013 Oct; 19(10):1132-41. PubMed ID: 23873778
[TBL] [Abstract][Full Text] [Related]
4. Significance of complement split product C4d in ABO-compatible liver allograft: diagnosing utility in acute antibody mediated rejection.
Ali S; Ormsby A; Shah V; Segovia MC; Kantz KL; Skorupski S; Eisenbrey AB; Mahan M; Huang MA
Transpl Immunol; 2012 Jan; 26(1):62-9. PubMed ID: 21907804
[TBL] [Abstract][Full Text] [Related]
5. Antibody-mediated rejection in the liver allograft.
Hübscher SG
Curr Opin Organ Transplant; 2012 Jun; 17(3):280-6. PubMed ID: 22569512
[TBL] [Abstract][Full Text] [Related]
6. Influence of preformed donor-specific antibodies and C4d on early liver allograft function.
Perera MT; Silva MA; Murphy N; Briggs D; Mirza DF; Neil DA
Scand J Gastroenterol; 2013 Dec; 48(12):1444-51. PubMed ID: 24131305
[TBL] [Abstract][Full Text] [Related]
7. Non-HLA Antibodies Impact on C4d Staining, Stellate Cell Activation and Fibrosis in Liver Allografts.
OʼLeary JG; Demetris AJ; Philippe A; Freeman R; Cai J; Heidecke H; Smith C; Hart B; Jennings LW; Catar R; Everly M; Klintmalm GB; Dragun D
Transplantation; 2017 Oct; 101(10):2399-2409. PubMed ID: 28665894
[TBL] [Abstract][Full Text] [Related]
8. Humoral Response in Liver Allograft Transplantation: A Review of the Role of Anti-Human Leukocyte Antigen (HLA) Antibodies.
Muro M; Moya-Quiles MR; Mrowiec A
Curr Protein Pept Sci; 2016; 17(8):776-784. PubMed ID: 26916161
[TBL] [Abstract][Full Text] [Related]
9. Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts.
Miyagawa-Hayashino A; Yoshizawa A; Uchida Y; Egawa H; Yurugi K; Masuda S; Minamiguchi S; Maekawa T; Uemoto S; Haga H
Liver Transpl; 2012 Nov; 18(11):1333-42. PubMed ID: 22888064
[TBL] [Abstract][Full Text] [Related]
10. Acute liver allograft antibody-mediated rejection: an inter-institutional study of significant histopathological features.
O'Leary JG; Michelle Shiller S; Bellamy C; Nalesnik MA; Kaneku H; Jennings LW; Isse K; Terasaki PI; Klintmalm GB; Demetris AJ
Liver Transpl; 2014 Oct; 20(10):1244-55. PubMed ID: 25045154
[TBL] [Abstract][Full Text] [Related]
11. Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts.
Kozlowski T; Andreoni K; Schmitz J; Hayashi PH; Nickeleit V
Liver Transpl; 2012 Jun; 18(6):641-58. PubMed ID: 22298469
[TBL] [Abstract][Full Text] [Related]
12. Markers of graft microvascular endothelial injury may identify harmful donor-specific anti-HLA antibodies and predict kidney allograft loss.
Louis K; Hertig A; Taupin JL; Buob D; Jamme M; Brocheriou I; Luque Y; Jouanneau C; Ouali N; Audouin M; Rondeau E; Xu-Dubois YC
Am J Transplant; 2019 Sep; 19(9):2434-2445. PubMed ID: 30836425
[TBL] [Abstract][Full Text] [Related]
13. The presence of anti-HLA donor-specific antibodies in lung allograft recipients does not correlate with C4d immunofluorescence in transbronchial biopsy specimens.
Roberts JA; Barrios R; Cagle PT; Ge Y; Takei H; Haque AK; Burns KM; Land GA; Dilioglou S; Bernard DW
Arch Pathol Lab Med; 2014 Aug; 138(8):1053-8. PubMed ID: 24164556
[TBL] [Abstract][Full Text] [Related]
14. Preformed donor-specific antibodies do not affect the 1-year allograft survival in living donor liver transplantation.
Kim H; Yi NJ; Song EY; Lee K; Lee KW; Lee HW; Ahn HY; Yoon KC; Hong SK; Suh KS
Clin Transplant; 2018 May; 32(5):e13244. PubMed ID: 29577436
[TBL] [Abstract][Full Text] [Related]
15. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
[TBL] [Abstract][Full Text] [Related]
16. De novo donor-specific anti-HLA antibodies mediated rejection in liver-transplant patients.
Del Bello A; Congy-Jolivet N; Danjoux M; Muscari F; Lavayssière L; Esposito L; Cardeau-Desangles I; Guitard J; Dörr G; Milongo D; Suc B; Duffas JP; Alric L; Bureau C; Guilbeau-Frugier C; Rostaing L; Kamar N
Transpl Int; 2015 Dec; 28(12):1371-82. PubMed ID: 26303035
[TBL] [Abstract][Full Text] [Related]
17. Acute antibody-mediated rejection after lung transplantation.
Witt CA; Gaut JP; Yusen RD; Byers DE; Iuppa JA; Bennett Bain K; Alexander Patterson G; Mohanakumar T; Trulock EP; Hachem RR
J Heart Lung Transplant; 2013 Oct; 32(10):1034-40. PubMed ID: 23953920
[TBL] [Abstract][Full Text] [Related]
18. Impacts of donor-specific anti-HLA antibodies and antibody-mediated rejection on outcomes after intestinal transplantation in children.
Petit LM; Rabant M; Canioni D; Suberbielle-Boissel C; Goulet O; Chardot C; Lacaille F
Pediatr Transplant; 2017 Mar; 21(2):. PubMed ID: 28084679
[TBL] [Abstract][Full Text] [Related]
19. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
[TBL] [Abstract][Full Text] [Related]
20. Plasma C4d+ Endothelial Microvesicles Increase in Acute Antibody-Mediated Rejection.
Tower CM; Reyes M; Nelson K; Leca N; Kieran N; Muczynski K; Jefferson JA; Blosser C; Kukla A; Maurer D; Chandler W; Najafian B
Transplantation; 2017 Sep; 101(9):2235-2243. PubMed ID: 27846156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]